Earlier, on January 17, Brottem acquired 9,090 shares of common stock without any cost, as part of performance-based restricted stock units that vested upon the satisfaction of specific performance criteria. Following these transactions, Brottem holds 181,188 shares of Outset Medical (TASE:PMCN) directly. The company maintains a strong liquidity position with a current ratio of 6.49, indicating solid short-term financial health. For comprehensive insider trading analysis and 12 additional key insights about Outset Medical, visit InvestingPro. The company maintains a strong liquidity position with a current ratio of 6.49, indicating solid short-term financial health. For comprehensive insider trading analysis and 12 additional key insights about Outset Medical, visit InvestingPro.
Earlier, on January 17, Brottem acquired 9,090 shares of common stock without any cost, as part of performance-based restricted stock units that vested upon the satisfaction of specific performance criteria. Following these transactions, Brottem holds 181,188 shares of Outset Medical directly.
"In other recent news, Outset Medical, Inc. has reported robust Q3 2024 results, with revenue reaching $28.7 million, surpassing guidance. Treatment revenue was up by 14% and service revenue by 22%. Despite a net loss of $20.2 million, this was an improvement from the previous year, and the company's gross margin improved to 36.4%. The company also raised its 2024 revenue guidance to approximately $112 million.
Simultaneously, Outset Medical completed a private placement offering and issued Series A Non-Voting Convertible Preferred Stock. The company also borrowed $100 million as an initial term loan from Perceptive Credit Holdings IV, LP, and issued a warrant for the purchase of over 5 million shares of its common stock.
On the analyst front, BTIG analyst Maria Thibault revised the price target for Outset Medical to $3.00, a decrease from the previous $4.00, while maintaining a Buy rating for the stock. These are recent developments that investors should be aware of."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.